Telomerase Activity Correlates with Growth of Transplantable Osteosarcomas in Rats Treated withcis-Diammine Dichloroplatinum or the Angiogenesis Inhibitor AGM-1470

This publication has 33 references indexed in Scilit:

• Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup
  The Lancet, 1997
• Efficacy of CDDP and AGM-1470 Chemotherapy Against Lung Metastasis in Rat Osteosarcoma Depends on the Timing of Combined Administration
  Japanese Journal of Clinical Oncology, 1997
• Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.
  1997
• p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats
  Cancer Letters, 1997
• Detection of Telomerase Activity in Malignant and Nonmalignant Skin Conditions
  Journal of Investigative Dermatology, 1996
• Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers
  JNCI: Journal of the National Cancer Institute, 1995
• Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470).
  1993
• Structure and function of telomeres
  Nature, 1991
• Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
  Nature, 1990
• TRANSPLANTABLE OSTEOSARCOMAS WITH HIGH LUNG METASTATIC POTENTIAL IN FISCHER 344 RATS
  Japanese Journal of Cancer Research, 1988